| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| F Mora, A Porra. Effects of amphetamine on the release of excitatory amino acid neurotransmitters in the basal ganglia of the conscious rat. Canadian journal of physiology and pharmacology. vol 71. issue 5-6. 1993-11-10. PMID:8104676. |
all these effects were blocked by the dopamine d1-d2 receptor blocker haloperidol. |
1993-11-10 |
2023-08-12 |
rat |
| P J Bren. Behavioural effect of pretreatment with opioid antagonists and sigma binding site ligands on the abnormal motor response produced by the kappa opioid agonist U50,488H in guinea pigs. Neuropharmacology. vol 32. issue 8. 1993-11-09. PMID:8413839. |
in contrast to the effect of haloperidol, pretreatment with the selective dopamine d-2 antagonist, raclopride (10 mg/kg, s.c.), had no significant effect on the abnormal movements induced by u50,488h, but did induce oral activity. |
1993-11-09 |
2023-08-12 |
Not clear |
| R E See, C Striplin, P W Kaliva. Chronic haloperidol does not alter G protein alpha-subunit levels in rats. Brain research. Molecular brain research. vol 19. issue 3. 1993-11-03. PMID:8412564. |
these results suggest that haloperidol administered in a regimen known to produce alterations in several parameters of dopamine function fails to alter the amount of receptor-linked g protein subunits in rat brain. |
1993-11-03 |
2023-08-12 |
rat |
| A B Sarmento, M C de Lima, C R Oliveir. Partition of dopamine antagonists into synthetic lipid bilayers: the effect of membrane structure and composition. The Journal of pharmacy and pharmacology. vol 45. issue 7. 1993-11-01. PMID:8105052. |
partition coefficients, kp, of four dopamine antagonists (pimozide, fluspirilene, haloperidol and domperidone) between the aqueous phase and lipid bilayer vesicles were determined as a function of lipid chain length, unsaturation and temperature encompassing the range of the lipid phase transition. |
1993-11-01 |
2023-08-12 |
Not clear |
| A Bairam, F Marchal, J P Crance, P Vert, S Lahir. Effects of doxapram on carotid chemoreceptor activity in newborn kittens. Biology of the neonate. vol 64. issue 1. 1993-11-01. PMID:8399797. |
group 1 (n = 9) received only doxapram and group 2 (n = 8) was pretreated with haloperidol (1 mg/kg), a dopamine d2-receptor blocker, before receiving doxapram. |
1993-11-01 |
2023-08-12 |
cat |
| B Glenthøj, J Mogensen, H Laursen, S Holm, R Hemmingse. Electrical sensitization of the meso-limbic dopaminergic system in rats: a pathogenetic model for schizophrenia. Brain research. vol 619. issue 1-2. 1993-10-20. PMID:8374792. |
the behavioral response to stimulation was suppressed both by the dopamine (da) d2 receptor antagonists haloperidol and raclopride and by the da d1 receptor antagonist sch 23390. |
1993-10-20 |
2023-08-12 |
rat |
| E Schlicker, K Fink, M Detzner, M Göther. Histamine inhibits dopamine release in the mouse striatum via presynaptic H3 receptors. Journal of neural transmission. General section. vol 93. issue 1. 1993-10-20. PMID:8396945. |
the degree of inhibition was increased to 38% by haloperidol but not affected by (1) atropine, (2) reducing the stimulation frequency to 0.3 hz or (3) increasing the concentration of [3h]dopamine (used for preincubation) to 100 nmol/l. |
1993-10-20 |
2023-08-12 |
mouse |
| C L Nilsson, E Eriksso. Haloperidol increases prolactin release and cyclic AMP formation in vitro: inverse agonism at dopamine D2 receptors? Journal of neural transmission. General section. vol 92. issue 2-3. 1993-10-12. PMID:7690232. |
haloperidol increases prolactin release and cyclic amp formation in vitro: inverse agonism at dopamine d2 receptors? |
1993-10-12 |
2023-08-12 |
Not clear |
| S O Ogren, B Pak. Effects of dopamine D1 and D2 receptor agonists and antagonists on seizures induced by chemoconvulsants in mice. Pharmacology & toxicology. vol 72. issue 4-5. 1993-10-12. PMID:8103921. |
the dopamine d2 antagonists remoxipride (5-20 mg/kg) and raclopride (5-20 mg/kg), haloperidol (2.5 and 5 mg/kg) and the d1 antagonist sch 23390 (0.3, 1.5 mg/kg) did not markedly modify seizures induced by pentylenetetrazole, picrotoxin or bicuculline. |
1993-10-12 |
2023-08-12 |
mouse |
| W F Gattaz, A Emrich, S Behren. Vitamin E attenuates the development of haloperidol-induced dopaminergic hypersensitivity in rats: possible implications for tardive dyskinesia. Journal of neural transmission. General section. vol 92. issue 2-3. 1993-10-12. PMID:8369109. |
chronic haloperidol treatment in rats results in behavioural supersensitivity to dopamine agonists. |
1993-10-12 |
2023-08-12 |
rat |
| L Peacock, J Gerlac. Effects of several partial dopamine D2 receptor agonists in Cebus apella monkeys previously treated with haloperidol. European journal of pharmacology. vol 237. issue 2-3. 1993-10-04. PMID:8103465. |
effects of several partial dopamine d2 receptor agonists in cebus apella monkeys previously treated with haloperidol. |
1993-10-04 |
2023-08-12 |
monkey |
| R A Lahti, D L Evans, N C Stratman, L M Figu. Dopamine D4 versus D2 receptor selectivity of dopamine receptor antagonists: possible therapeutic implications. European journal of pharmacology. vol 236. issue 3. 1993-09-30. PMID:8102973. |
compounds with considerable selectivity for the dopamine d2 receptor were haloperidol (0.31), chlorpromazine (0.084), trifluoperazine (0.034) and raclopride (0.001). |
1993-09-30 |
2023-08-12 |
Not clear |
| T Y Lo. Dopamine depresses non-adrenergic, non-cholinergic neurotransmission in the rat bladder. The Journal of pharmacy and pharmacology. vol 45. issue 6. 1993-09-30. PMID:8103108. |
the depressant action of dopamine on nanc transmission was not mediated by blockade of purinergic receptors, but was partially reversed by haloperidol. |
1993-09-30 |
2023-08-12 |
rat |
| D J Dobie, K M Merchant, M W Hamblin, G T Vatassery, M W Dysken, D M Dors. Blunting of the neurotensin mRNA response to haloperidol in the striatum of aging rats: possible relationship to decline in dopamine D2 receptor expression. Brain research. vol 616. issue 1-2. 1993-09-30. PMID:8358601. |
blunting of the neurotensin mrna response to haloperidol in the striatum of aging rats: possible relationship to decline in dopamine d2 receptor expression. |
1993-09-30 |
2023-08-12 |
rat |
| O Grigoriants, L Devi, L D Fricke. Dopamine antagonist haloperidol increases carboxypeptidase E mRNA in rat neurointermediate pituitary but not in various other rat tissues. Brain research. Molecular brain research. vol 19. issue 1-2. 1993-09-30. PMID:8361339. |
dopamine antagonist haloperidol increases carboxypeptidase e mrna in rat neurointermediate pituitary but not in various other rat tissues. |
1993-09-30 |
2023-08-12 |
rat |
| N A Moore, A Blackman, S Awere, J D Leande. NMDA receptor antagonists inhibit catalepsy induced by either dopamine D1 or D2 receptor antagonists. European journal of pharmacology. vol 237. issue 1. 1993-09-28. PMID:8359205. |
in the present study, we investigated the ability of nmda receptor antagonists to inhibit catalepsy induced by haloperidol, or sch23390 and clebopride, selective dopamine d1 and d2 receptor antagonists respectively. |
1993-09-28 |
2023-08-12 |
Not clear |
| F Cresp. Functional in vivo interaction between growth hormone and dopamine systems are correlated to changes in striatal somatostatin levels as detected by voltammetry. Experimental brain research. vol 94. issue 3. 1993-09-24. PMID:8102978. |
the effects of growth hormone (gh) and somatomedin c (smc), as well as those of apomorphine, dopamine (da) agonist, or haloperidol (da antagonist), upon the size of striatal voltammetric peaks 2 and 5 were investigated. |
1993-09-24 |
2023-08-12 |
rat |
| S M Sorensen, J H Kehne, G M Fadayel, T M Humphreys, H J Ketteler, C K Sullivan, V L Taylor, C J Schmid. Characterization of the 5-HT2 receptor antagonist MDL 100907 as a putative atypical antipsychotic: behavioral, electrophysiological and neurochemical studies. The Journal of pharmacology and experimental therapeutics. vol 266. issue 2. 1993-09-17. PMID:8102646. |
consistent with their acute effect on a9 and a10 activity, neither mdl 100,907 nor clozapine increased dopamine metabolism in the striatum or nucleus accumbens, whereas acute haloperidol accelerated dopamine turnover in both regions. |
1993-09-17 |
2023-08-12 |
mouse |
| S M Sorensen, J H Kehne, G M Fadayel, T M Humphreys, H J Ketteler, C K Sullivan, V L Taylor, C J Schmid. Characterization of the 5-HT2 receptor antagonist MDL 100907 as a putative atypical antipsychotic: behavioral, electrophysiological and neurochemical studies. The Journal of pharmacology and experimental therapeutics. vol 266. issue 2. 1993-09-17. PMID:8102646. |
the administration of the dopamine uptake blocker amfonelic acid with haloperidol produced a massive increase in da metabolism characteristic of typical antipsychotics. |
1993-09-17 |
2023-08-12 |
mouse |
| S J Hong, G C Chio. Effects of dopamine agonists and antagonists on pulsatile blood flow of ocular hypertensive rabbits. Journal of ocular pharmacology. vol 9. issue 2. 1993-09-07. PMID:8102175. |
it was found that numerous dopamine antagonists including loxapine, moperone, domperidone, haloperidol and metoclopramide increased pulsatile blood flow for 49-110%, 95-155%, 72-86%, 60-114%, and 39-139%, respectively. |
1993-09-07 |
2023-08-12 |
Not clear |